CRISPR Therapeutics' revenue streams currently rely heavily on grants and collaboration revenues from its partnership with Vertex Pharmaceuticals (VRTX). The collaboration has yielded Casgevy, a ...

This is an important study utilizing innovative CRISPR based approaches demonstrating the role of the KLF family of transcription factors in the post natal maturation of cortical projection neurons.

We expect Vertex Pharmaceuticals Incorporated VRTX to surpass expectations when it reports first-quarter 2025 results on May ...

Explore incredible new inventions that are transforming the planet in this exciting video! From sustainable energy innovations like tidal power to cutting-edge advancements in biotechnology and ...

The question we face isn’t whether AI will carry forward our memories. It already does. The real question is whether we have ...

Repare Therapeutics Inc.’s RPTX share price has surged by 5.60%, which has investors questioning if this is right time to ...

Joanna Sugden is a foreign news editor for The Wall Street Journal based in London.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...